Skip to main content

Advertisement

Table 1 Preoperative demographic data, clinical characteristics and severity of coronary heart disease in 910 patients surviving two months after CABG

From: Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG

  DM–/MetS– DM–/MetS+ DM+ Overall
  n = 375 n = 279 n = 256 p-value
Female (%) 15.2 26.2 23.8 <0.011,2
Mean Age (years) (SD) 61.3 (8.2) 60.7 (8.6) 63.3 (8.4) <0.0012,3
Variables of Modified MetS
BMI (kg/ m 2 ) 25.8 28.7 28.1 NA
Elevated Blood Pressure (%) 40.9 83.1 67.5  
HDL Cholesterol (low, %) 44.9 90.2 65.3  
Triglyceride (high, %) 27.4 83.7 67.7  
Elevated Glucose or DM (%) 4.5 25.8 100.0  
Concomitant Diseases
Hypercholesterolemia (%) 69.5 80.3 77.7 NS
Previous MI (%) 70.5 67.8 67.7 NS
Previous TIA or stroke (%) 8.9 8.6 13.9 NS
Intermittent Claudication (%) 6.2 4.7 18.6 <0.0013,4
Renal Function
CreaCl (ml/min) (SD) 76.4 (13.8) 74.2 (18.2) 73.7 (16.9) NS
CreaCl < 60 ml/min/1,73 m 2 (%) 11.0 19.0 19.7 <0.011,2
Preoperative Smoking (%) 66.6 60.2 66.4 NS
Severity of Heart Disease
EF (%) (SD) 60 (14) 61 (13) 58 (14) <0.055
EF ≤ 35% (%) 7 4 11 <0.055
NYHA II (%) 11.9 13.0 6.5  
NYHA III (%) 59.9 54.3 56.3 <0.055
NYHA IV (%) 28.2 32.6 37.2  
Operation Characteristics
Three–vessel Disease (%) 61.1 59.7 58.6 NS
Left Main Disease (%) 13.1 16.6 14.1 NS
Number of Grafts 3.39 3.38 3.35 NS
Use of Arterial Grafts (%) 86.3 83.4 81.0 NS
Concomitant Operation (%) 6.1 3.3 7.6 NS
Perfusion Time (SD) 107.0 (36.6) 108.0 (58.8) 112.3 (34.2) NS
Urgent or Emergency Operation (%) 26.7 29.9 33.5 NS
  1. Abbreviations: MI myocardial infarct, TIA transient ischemic attack, EF ejection fraction, NYHA angina pectoris symptoms according to New York Heart Association, CHD coronary heart disease, LM left main, low HDL cholesterol: men < 1.03 mmol/l, women < 1.3 mmol/l, elevated triglycerides: ≥ 1.7 mmol/l, NS = not significant, NA = not applicable.
  2. 1Unadjusted p < 0.01 by the pooled t-test for the comparison DM-/MetS+ against DM-/MetS-.
  3. 2Unadjusted p < 0.01 by the pooled t-test for the comparison DM+ against DM-/MetS-.
  4. 3Unadjusted p < 0.001 by the pooled t-test for the comparison DM+ against DM-/MetS+.
  5. 4Unadjusted p < 0.001 by the pooled t-test for the comparison DM+ against DM-/MetS-.
  6. 5Unadjusted p < 0.05 by the pooled t-test for the comparison DM+ against other groups.